Search / Trial NCT06611280

Deuterium Metabolic Imaging in People with Multiple Sclerosis

Launched by UNIVERSITY OF AARHUS · Sep 20, 2024

Trial Information

Current as of October 09, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aged 18-60 years.
  • * Definite Relapsing remitting multiple sclerosis diagnosis according to the most recent diagnostic criteria
  • Exclusion Criteria:
  • * Contraindications for MRI:
  • Pacemaker, neurostimulator or cholera implant. Metal foreign bodies such as fragments and irremovable piercings. Unsafe medical implants (safety of heart valves, hips and the like must be confirmed).
  • Claustrophobia. Largest circumference including arms \> 160 cm
  • * Pregnancy
  • * Competing neurological, psychiatric, or systemic diseases including diabetes (except prior TIA, unspecific brain MRI findings, hypertension, atherosclerosis and hyperlipidemia/cholesterolemia which are allowed).
  • * Participating in other clinical trials with investigational medical products or drugs.

About University Of Aarhus

The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0